Drug Shortage Report for DYSPORT AESTHETIC
Report ID | 159136 |
Drug Identification Number | 02387735 |
Brand name | DYSPORT AESTHETIC |
Common or Proper name | abobotulinumtoxinA |
Company Name | IPSEN BIOPHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ABOBOTULINUMTOXINA |
Strength(s) | 300UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1 vial |
ATC code | M03AX |
ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-05-04 |
Actual start date | 2022-05-04 |
Estimated end date | 2022-05-20 |
Actual end date | 2022-05-20 |
Shortage status | Resolved |
Updated date | 2022-05-21 |
Company comments | Dysport 300u product has seen a significant increase in demand driven by Aesthetic growth. Ipsen are implementing supply capacity improvement projects in order to meet this new growth. During this interim period there will be stock constraints. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5050 SATELLITE DRIVE MISSISSAUGA, ONTARIO CANADA L4W 0G1 |
Company contact information | medinfoandsafetycanada@ipsen.com 1(855) 215-2288 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-05-21 | English | Compare |
v8 | 2022-05-20 | French | Compare |
v7 | 2022-05-20 | English | Compare |
v6 | 2022-05-05 | English | Compare |
v5 | 2022-04-29 | French | Compare |
v4 | 2022-04-29 | English | Compare |
v3 | 2022-04-29 | English | Compare |
v2 | 2022-04-21 | French | Compare |
v1 | 2022-04-21 | English | Compare |
Showing 1 to 9 of 9